MEERA NAIR: Open Payments
NPI 1245804640 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,110 in 13 payments from 7 companies in 2025. Trend: 2023 $528 · 2024 $694 · 2025 $1,110
Food & beverage: $1,110
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 4 | $286 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $275 |
| Axsome Therapeutics, Inc. | 1 | $143 |
| Brainsway USA INC | 1 | $135 |
| Neurocrine BioSciences, Inc. | 1 | $122 |
| Janssen Pharmaceuticals, Inc | 1 | $121 |
| Vanda Pharmaceuticals Inc. | 1 | $29 |
Products named: CAPLYTA, COBENFY, Auvelity, Deep TMS, INGREZZA, SPRAVATO, FANAPT.
Industry payments across IL — which companies pay providers there.
